Coronary-coronary bypass grafting to reduce the risk of aortic atheroembolism

Adnan Yalcinkaya1, Kumral Ergun Cagli, Mahmut M Ulas

  • 1Department of Cardiovascular Surgery, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey. adnanyalcinkaya@gmail.com

Journal of Cardiac Surgery
|December 31, 2009
PubMed

Insights

Coronary-coronary bypass grafting offers a less invasive approach for patients with severe aortic atherosclerosis. This technique involves connecting coronary artery segments, reducing aortic manipulation during off-pump surgery.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Anastomosis Techniques
  • Atherosclerosis Research

Background:

  • Coronary artery bypass grafting (CABG) is a standard treatment for coronary artery disease.
  • Severe ascending aorta atherosclerosis poses a challenge for traditional CABG due to increased stroke risk.
  • Coronary-coronary bypass grafting (CCBG) minimizes aortic manipulation, offering an alternative for high-risk patients.

Observation:

  • A case involving a patient with extensive atherosclerotic aorta is presented.
  • The patient underwent off-pump coronary artery bypass grafting (OPCABG) surgery.
  • A saphenous vein graft was utilized for the procedure.

Findings:

  • The saphenous vein graft was successfully anastomosed between the acute marginal and posterior-descending branches of the right coronary artery.
  • This coronary-coronary bypass (CCB) strategy was employed during off-pump coronary artery bypass grafting (OPCABG).
  • The procedure aimed to bypass diseased segments without direct aortic manipulation.

Implications:

  • Coronary-coronary bypass grafting (CCBG) represents a viable strategy for patients with severe aortic disease undergoing coronary artery bypass grafting (CABG).
  • Off-pump coronary artery bypass grafting (OPCABG) combined with CCBG may reduce perioperative risks associated with aortic manipulation.
  • This approach highlights the adaptability of surgical techniques to manage complex coronary artery disease in the presence of significant atherosclerosis.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...